Tessera
Folgen

Therapeutics Initiative (TI)

@drug-evidence.bsky.social

Independent, evidence-informed, practical #BetterPrescribing resources for physicians, pharmacists, & nurse practitioners. Based in the University of British Columbia's Faculty of Medicine, Department of Anesthesiology, Pharmacology & Therapeutics.

688 Posts1516 Follower1415 Folgt
Therapeutics Initiative (TI)@drug-evidence.bsky.social ยท 2d ago

๐Ÿšจ Webinar: Audit & Feedback for Reducing Low-Value Testing Exploring how healthcare teams can: โœ… Reduce unnecessary testing โœ… Improve patient care โœ… Ensure efforts to โฌ‡๏ธ unnecessary testing are fair+equitable ๐Ÿ—“๏ธ Thu Sept 24 @ 9am Pacific โœ๏ธ Register: bit.ly/46JwOFd #MedEd #LabTests #Overdiagnosis

Welcome! You are invited to join a webinar: Rethinking Routine: Audit and Feedback for Reducing Low-Value Testing. After registering, you will receive a confirmation email about joining the webinar.

This webinar will explore how healthcare teams can reduce unnecessary tests and improve patient care using two practical approaches: audit and feedback, which helps clinicians understand and improve t...

bit.ly

deprescribing.org@deprescribing.bsky.social ยท 2w ago

Find guidance on deprescribing benzodiazepines or opioids (when medically appropriate) on our Deprescribing Guidelines Repository (DEPOT) page: buff.ly/2Buy8U2

Deprescribing Guidelines Repository (DEPOT) - Deprescribing.org

A resource for guideline developers to share their guidelines and for guideline users to access deprescribing guidance. This public-facing central repository is a place where deprescribing guidelineโ€ฆ

deprescribing.org

Michael Sykes @msykes.bsky.social ยท 4d ago

๐Ÿคฉ This looks excellent!! ๐Ÿคฉ "Reducing Low-Value Testing" by two wonderful academics, Drs Nicola McCleary and Anshula Ambasta.

Therapeutics Initiative (TI)@drug-evidence.bsky.social ยท 4d ago

๐Ÿ†• Webinar: Audit & Feedback for Reducing Low-Value Testing Exploring how healthcare teams can: โœ… Reduce unnecessary testing โœ… Improve patient care โœ… Ensure efforts to โฌ‡๏ธ unnecessary testing are fair+equitable ๐Ÿ—“๏ธ Thu Sept 24 @ 9am Pacific โœ๏ธ Register: bit.ly/46JwOFd #MedEd #LabTests #Overdiagnosis

Therapeutics Initiative (TI)@drug-evidence.bsky.social ยท 4d ago

๐Ÿ†• Webinar: Audit & Feedback for Reducing Low-Value Testing Exploring how healthcare teams can: โœ… Reduce unnecessary testing โœ… Improve patient care โœ… Ensure efforts to โฌ‡๏ธ unnecessary testing are fair+equitable ๐Ÿ—“๏ธ Thu Sept 24 @ 9am Pacific โœ๏ธ Register: bit.ly/46JwOFd #MedEd #LabTests #Overdiagnosis

Welcome! You are invited to join a webinar: Rethinking Routine: Audit and Feedback for Reducing Low-Value Testing. After registering, you will receive a confirmation email about joining the webinar.

This webinar will explore how healthcare teams can reduce unnecessary tests and improve patient care using two practical approaches: audit and feedback, which helps clinicians understand and improve t...

bit.ly

deprescribing.org@deprescribing.bsky.social ยท 3w ago

๐Ÿซต Are YOU familiar with the "5 Tips to Manage Polypharmacy" Toolkit developed in collaboration between @deprescribing.bsky.social, ISMP Canada, & Canada's Drug Agency? Our 5th Tip: 5๏ธโƒฃ "๐ƒ๐ž๐ฉ๐ซ๐ž๐ฌ๐œ๐ซ๐ข๐›๐ž ๐š๐ง๐ ๐’๐ข๐ฆ๐ฉ๐ฅ๐ข๐Ÿ๐ฒ ๐ญ๐จ ๐‘๐ž๐๐ฎ๐œ๐ž ๐Œ๐ž๐๐ข๐œ๐š๐ญ๐ข๐จ๐ง ๐๐ฎ๐ซ๐๐ž๐ง" Find the full toolkit here: buff.ly/ltjmX4Q

BildBildBild
Therapeutics Initiative (TI)@drug-evidence.bsky.social ยท 3w ago

ICYMI: UBC TI #BestEvidence webinar recording Using your TI Portrait & mysleepwell.ca for optimal #insomnia management ๐ŸŽค Speakers: Dr. Aaron Tejani + Dr. David Gardner ๐Ÿ‘ฉ๐Ÿฝโ€๐Ÿ’ป Video: www.youtube.com/watch?v=jC9g... #PrescribingPortraits #MedEd #deprescribing

Dr Aaron Tejani + Dr David Gardner: TI Portrait & mysleepwell.ca for optimal management of insomnia

YouTube video by Therapeutics Initiative

youtube.com

Therapeutics Initiative (TI)@drug-evidence.bsky.social ยท 3w ago

๐ŸŽบ UBC TI #SystematicReview Glucagon-like peptide-1 receptor agonists for primary cardiovascular disease prevention in #T2DM drc.bmj.com/content/14/4... Current evidence insufficient to establish cardiovascular benefit of GLP-1 RAs in primary #CVD prevention #GLP1 #diabetes #MedEd

Glucagon-like peptide-1 receptor agonists for primary cardiovascular disease prevention in type 2 diabetes, a systematic review

We aimed to estimate the cardiovascular (CV) benefit of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in patients with type 2 diabetes (T2D) without a history of CV disease (CVD) (primary CVD ...

drc.bmj.com

Therapeutics Initiative (TI)@drug-evidence.bsky.social ยท 3w ago

๐Ÿ†• UBC TI #SystematicReview ๐Ÿ†• Glucagon-like peptide-1 receptor agonists for primary cardiovascular disease prevention in #T2DM drc.bmj.com/content/14/4... Current evidence insufficient to establish cardiovascular benefit of GLP-1 RAs in primary #CVD prevention #GLP1 #diabetes #MedEd

Glucagon-like peptide-1 receptor agonists for primary cardiovascular disease prevention in type 2 diabetes, a systematic review

We aimed to estimate the cardiovascular (CV) benefit of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in patients with type 2 diabetes (T2D) without a history of CV disease (CVD) (primary CVD ...

drc.bmj.com